IHE-Europe launches health IT interoperability testing service

IHE-Europe, a nonprofit association dedicated to interoperability in health IT, has launched IHE-Services, a health IT connectivity and interoperability testing service that the Belgium-based organization believes will benefit large-scale health IT initiatives and efforts to design new health IT products.

“The lack of interoperability between the systems used by different healthcare providers has been the greatest obstacle to a wider use of IT for better healthcare,” IHE-Europe Users’ Co-Chair Jacqueline Surugue said.

“Offering a responsive service with access to the testing tools and expertise developed for IHE-Europe responds to a growing demand from e-health initiatives across Europe,” she continued.

IHIE-Europe partnered with Kereval, a software testing company, and Inria, a computer science research firm, in order to make the vendor-neutral IHE-Services available.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.